Pressure Biosciences

Greetings. Welcome to the Pressure Biosciences Q3 and Year-to-Date Investor Call and Business Update. At this time, all participants are in a listen-only mode. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note, this conference is being recorded. I will now turn the conference over to your host, Richard Schumacher, President and CEO. You may begin.

Thank you, John. Appreciate it. And thanks, everybody, for joining us. I know It's not as convenient as usual. This is a holiday week, and some of you may actually already have started your holiday, so I apologize that it ran into a holiday week, but we had a number of things that we had to get done with our auditors to make sure everything was in there, and we did, and we couldn't get it done, and I didn't want to file it on a Friday, so we filed it yesterday. So if I forget, I want to wish everybody a happy Thanksgiving and a happy holiday. Um, some of you, I know many of you personally, some of you know that I went through hell. Um, in August I had open heart surgery. Um, I had triple bypass and aortic valve replaced. And, uh, so for me, I have a lot personally this year, uh, in addition to my normal to thank, uh, to give thanks for. So I'm back. I'm at it. I've been at it for a number of weeks now. So don't take anything for granted. I'm a healthy guy. I walk a lot every day. But one day, my chest started hurting. And a month later, I was in for a six and a half hour operation. So guys, we all have something to give many things to give thanks about. And let's remember that on Thanksgiving, and every day. So I'm going to start by reading some remarks that we need to read up front. The following remarks may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risk, uncertainties, and other factors which may cause the actual results, performance, or achievements of the company to be material or different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors include, among others, those detailed from time to time in the company's filings with the Securities and Exchange Commission. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or change in events, conditions, or circumstances on which any such statement is based. The agenda today is similar to the agendas of the past. First, I want to welcome back to the PBI Financial Review and Business Update, Jeff Peterson. Jeff is PBI's Board Chairman. Welcome, Jeff.

A pleasure to join you again.